MMS officers frequently offer testimony and/or legal perspectives to state and federal officials on issues relevant to Massachusetts physicians and their patients.
Comments of the Massachusetts Medical Society Regarding the Health Policy Commission 2018 Health Care Cost Benchmark
March 10, 2017
MMS Comments Regarding Proposed Regulatory Changes to the Board of Regulation in Medicine
March 1, 2017
Comments Regarding Department of Public Health's Proposed Changes to the Regulations, List of Interchangeable Drug Products
January 24, 2017
Comments Regarding Center for Health Information and Analysis Proposed Methodology For Referring Health-Care Entitites to the Health Policy Commission
December 9, 2016
Comments Regarding the Health Information Exchange Regulations
November 29, 2016
The Medical Society supports the proposed approach to patient consent for use of the Mass HIway. The thoughtful proposal would allow for 1) general HIPAA compliance to govern HIway direct messaging, and 2) a consent process for HIway sponsored services that allows patients to be opted-in through...
Testimony Relative to the Determination of Needs Regulations Before the Public Health Council
September 29, 2016
The Massachusetts Medical Society greatly appreciates the opportunity to provide comment on the Department of Public Health’s proposed revision to the Determination of Need (DON) regulations (105 CMR 100.000). The Medical Society commends the Department in its desire to reform the DON program; few...
MMS Testimony Relative to Proposed Amendments to MassHealth Billing Regulations
July 22, 2016
The Massachusetts Medical Society wishes to convey its strong disagreement with the proposed amendments to MassHealth administrative and billing regulations (130 CMR 450.000). These regulations would place an unreasonable timeline on the new requirement that all physicians become MassHealth...
MMS Testimony Relative to MassHealth Section 1115 Demonstration Project Amendment and Extension Request
July 15, 2016
The Massachusetts Medical Society appreciates the opportunity to provide comment on the MassHealth Section 1115 Demonstration Project Amendment and Extension Request. We applaud the transparent and inclusive process Assistant Secretary Tsai and his office has undertaken over the past many months...
MMS Testimony Relative to House 4188, An Act Relative to State Oversight of Professional Licensing Boards
May 12, 2016
The Massachusetts Medical Society (MMS) appreciates the opportunity to provide comment relative to and to express concern about House bill 4188, “An Act Relative to State Oversight of Professional Licensing Boards.” The Medical Society supports the intent of the bill, as indicated on the...
MMS Testimony Relative to S. 1048, An Act to Promote Transparency and Cost Control of Pharmaceutical Drug Prices
April 11, 2016
The Massachusetts Medical Society has prioritized finding solutions to the rising costs of pharmaceutical drugs. Far too often, high prices impede on the ability for patients to access the best treatments. The Society is actively working on this issue at the federal level, and has recently met with...
MMS Testimony in Opposition to House 4062, An Act Relative to Benzopiazapines and Non-Benzodiazepine Hypnotics
April 4, 2016
The Medical Society strongly supports the careful prescribing of benzodiazepines given concerns over addiction, over polypharmacy abuse with opioids, and given the clinical acuity of the detoxification process from benzodiazepines. Many of the continuing medical education courses that we provide...
MMS Testimony in Support of Senate 1114, An Act to Eliminate Health Disparities in the Commonwealth
March 22, 2016
The Massachusetts Medical Society wishes to be recorded in support of S.1114, legislation that would establish an Office of Health Equity in the Executive Office of Health and Human Services to provide both coordination of – and accountability for – all state efforts to reduce health disparities...